Jun 20, 2023 by James HalleyWhy Shares of Zura Bio Climbed TuesdayThe biotech stock continued its rise in June.
Jun 20, 2023 by James HalleyWhy Shares of Cano Health Jumped on TuesdayOver the weekend, the company announced a leadership change.
Jun 20, 2023 by James HalleyWhy Shares of Dice Therapeutics Are Skyrocketing TuesdayThe company received a buyout offer from Eli Lilly.
Jun 20, 2023 by James HalleyIf You Own These 3 Growth Stocks, You Might Want to Rethink Your PositionAll three healthcare stocks have soared this year, but their share prices may not be sustainable.
Jun 17, 2023 by James Halley3 Cathie Wood Investments That Could Deliver Superior ReturnsThese three stocks fit Wood's profile for big-time growth.
Jun 16, 2023 by James HalleyWhy Shares of Adaptive Biotechnologies Jumped This WeekThe company could see its first FDA-approved therapy as early as next year.
Jun 16, 2023 by James HalleyWhy Shares of Fate Therapeutics Soared This WeekThe company's shares bounced back after a stock sale last week.
Jun 16, 2023 by James HalleyWhy Shares of Schrödinger Rose This WeekInterest in the company's AI platform continues to drive the stock.
Jun 16, 2023 by James HalleyWhy Shares of Lyell Immunopharma Jumped This WeekThe company gave a presentation regarding its lead therapy to treat solid tumors.
Jun 14, 2023 by James HalleyWhy Shares of UnitedHealth Group Are Dropping WednesdayThe healthcare insurer is warning of rising costs from non-necessary surgeries.
Jun 14, 2023 by James HalleyWhy Shares of Zynex Are Up WednesdayAfter buying back $30 million in stock over the past 12 months, the company is now planning a $10 million stock buyback.
Jun 14, 2023 by James HalleyWhere Will CRISPR Therapeutics Be in 10 Years?The biotech is part of a revolution in gene-editing therapies.
Jun 13, 2023 by James HalleyWhy Shares of Gracell Biotechnologies Jumped TuesdayGracell climbed higher for a second consecutive day.
Jun 13, 2023 by James HalleyWhy Shares of Surmodics Soared on TuesdayAn analyst upgrade gave the stock a boost.
Jun 13, 2023 by James HalleyWhy Shares of Akoya Biosciences Jumped on TuesdayA rash of insider buying buoyed investor confidence in the medical instrument company.
Jun 12, 2023 by James HalleyWhy Shares of Omeros Dropped on MondayThe clinical-stage biopharmaceutical released trials data through a presentation.
Jun 12, 2023 by James HalleyWhy Shares of Chinook Therapeutics Skyrocketed On MondayThe company, which specializes in treating kidney diseases, agreed to a buyout offer.
Jun 12, 2023 by James HalleyWhy Shares of Vera Therapeutics Are Soaring MondayThe company, which specializes in autoimmune disorders affecting the kidney, benefited from a renewed interest in kidney therapies.
Jun 10, 2023 by James HalleyBetter Long-Term Buy: AbbVie or Novo Nordisk?It's important to factor in a pharmaceutical company's pipeline depth.
Jun 9, 2023 by James HalleyWhy Shares of Arcutis Biotherapeutics Jumped This WeekThe stock got a push when a British medical journal posted trials information on the company's lead product.
